GLAUKOS Corp Cost of Revenue
GLAUKOS Corp (GKOS) reported Cost of Revenue of $34.02 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-07-29
- GLAUKOS Corp cost of goods and services sold for the quarter ending 2026-06-30 was $34.02M, a 26.47% increase year-over-year.
- GLAUKOS Corp cost of goods and services sold for the quarter ending 2026-03-31 was $33.34M, a 37.11% increase year-over-year.
- GLAUKOS Corp cost of goods and services sold for the quarter ending 2025-12-31 was $31.77M, a 10.95% increase year-over-year.
- GLAUKOS Corp cost of goods and services sold for the quarter ending 2025-09-30 was $28.83M, a 27.66% increase year-over-year.
- GLAUKOS Corp cost of goods and services sold for fiscal 2025 was $111.81M, a 18.92% increase from fiscal 2024.
- GLAUKOS Corp cost of goods and services sold for fiscal 2024 was $94.03M, a 24.42% increase from fiscal 2023.
- GLAUKOS Corp cost of goods and services sold for fiscal 2023 was $75.58M, a 9.56% increase from fiscal 2022.
- GLAUKOS Corp cost of goods and services sold for fiscal 2022 was $68.98M, a 3.53% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $34.02M 10-Q · filed 2026-07-29 | $67.36M 10-Q · filed 2026-07-29 | $99.13M derived: sum of 3 quarters · filed 2026-07-29 | $127.96M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $33.34M 10-Q · filed 2026-04-30 | $65.11M derived: sum of 2 quarters · filed 2026-04-30 | $93.94M derived: sum of 3 quarters · filed 2026-04-30 | $120.84M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $31.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $60.60M derived: sum of 2 quarters · filed 2026-02-23 | $87.50M derived: sum of 3 quarters · filed 2026-07-29 | $111.81M 10-K · filed 2026-02-23 |
| 2025-09-30 | $28.83M 10-Q · filed 2025-10-31 | $55.73M derived: sum of 2 quarters · filed 2026-07-29 | $80.04M 10-Q · filed 2025-10-31 | $108.68M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $26.90M 10-Q · filed 2026-07-29 | $51.21M 10-Q · filed 2026-07-29 | $79.85M derived: sum of 3 quarters · filed 2026-07-29 | $102.43M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $24.32M 10-Q · filed 2026-04-30 | $52.95M derived: sum of 2 quarters · filed 2026-04-30 | $75.53M derived: sum of 3 quarters · filed 2026-04-30 | $98.08M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $28.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $51.22M derived: sum of 2 quarters · filed 2026-02-23 | $73.77M derived: sum of 3 quarters · filed 2026-02-23 | $94.03M 10-K · filed 2026-02-23 |
| 2024-09-30 | $22.58M 10-Q · filed 2025-10-31 | $45.13M derived: sum of 2 quarters · filed 2025-10-31 | $65.39M 10-Q · filed 2025-10-31 | $84.28M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $22.55M 10-Q · filed 2025-08-04 | $42.81M 10-Q · filed 2025-08-04 | $61.70M derived: sum of 3 quarters · filed 2026-02-23 | $80.21M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $20.26M 10-Q · filed 2025-05-01 | $39.15M derived: sum of 2 quarters · filed 2026-02-23 | $57.66M derived: sum of 3 quarters · filed 2026-02-23 | $77.76M derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $18.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $37.40M derived: sum of 2 quarters · filed 2026-02-23 | $57.50M derived: sum of 3 quarters · filed 2026-02-23 | $75.58M 10-K · filed 2026-02-23 |
| 2023-09-30 | $18.51M 10-Q · filed 2024-11-05 | $38.61M derived: sum of 2 quarters · filed 2024-11-05 | $56.68M 10-Q · filed 2024-11-05 | $73.91M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $20.10M 10-Q · filed 2024-08-02 | $38.17M 10-Q · filed 2024-08-02 | $55.40M derived: sum of 3 quarters · filed 2024-08-02 | $72.26M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $18.07M 10-Q · filed 2024-05-03 | $35.29M derived: sum of 2 quarters · filed 2024-05-03 | $52.15M derived: sum of 3 quarters · filed 2024-05-03 | $69.99M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $17.22M 10-K · filed 2023-02-24 | $34.08M derived: sum of 2 quarters · filed 2023-11-01 | $51.92M derived: sum of 3 quarters · filed 2023-11-01 | $68.98M 10-K · filed 2025-02-25 |
| 2022-09-30 | $16.86M 10-Q · filed 2023-11-01 | $34.69M derived: sum of 2 quarters · filed 2023-11-01 | $51.76M 10-Q · filed 2023-11-01 | $68.62M derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | $17.83M 10-Q · filed 2023-08-02 | $34.90M 10-Q · filed 2023-08-02 | $51.76M derived: sum of 3 quarters · filed 2023-08-02 | $67.13M derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $17.06M 10-Q · filed 2023-05-04 | $33.93M derived: sum of 2 quarters · filed 2023-05-04 | $49.30M derived: sum of 3 quarters · filed 2023-05-04 | $67.06M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $16.86M 10-K · filed 2023-02-24 | $32.23M derived: sum of 2 quarters · filed 2023-02-24 | $49.99M derived: sum of 3 quarters · filed 2023-02-24 | $66.63M 10-K · filed 2024-02-23 |
| 2021-09-30 | $15.37M 10-K · filed 2023-02-24 | $33.13M derived: sum of 2 quarters · filed 2023-02-24 | $49.76M 10-Q · filed 2022-11-04 | $69.35M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $17.76M 10-K · filed 2023-02-24 | $34.39M 10-Q · filed 2022-08-05 | $53.98M derived: sum of 3 quarters · filed 2023-02-24 | $71.91M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $16.63M 10-K · filed 2023-02-24 | $36.22M derived: sum of 2 quarters · filed 2023-02-24 | $54.16M derived: sum of 3 quarters · filed 2023-02-24 | $75.82M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $19.59M 10-K · filed 2022-02-28 | $37.52M derived: sum of 2 quarters · filed 2022-02-28 | $59.19M derived: sum of 3 quarters · filed 2022-02-28 | $91.72M 10-K · filed 2023-02-24 |
| 2020-09-30 | $17.93M 10-K · filed 2022-02-28 | $39.60M derived: sum of 2 quarters · filed 2022-02-28 | $72.13M 10-Q · filed 2021-11-08 | $88.03M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $21.67M 10-K · filed 2022-02-28 | $54.20M 10-Q · filed 2021-08-05 | $70.10M derived: sum of 3 quarters · filed 2022-02-28 | $77.80M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $32.53M 10-K · filed 2022-02-28 | $48.43M derived: sum of 2 quarters · filed 2022-02-28 | $56.14M derived: sum of 3 quarters · filed 2022-02-28 | $64.01M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $15.90M 10-K · filed 2021-03-01 | $23.61M derived: sum of 2 quarters · filed 2021-03-01 | $31.48M derived: sum of 3 quarters · filed 2021-03-01 | $38.59M 10-K · filed 2022-02-28 |
| 2019-09-30 | $7.70M 10-K · filed 2021-03-01 | $15.57M derived: sum of 2 quarters · filed 2021-03-01 | $22.68M 10-Q · filed 2020-11-05 | $29.80M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $7.87M 10-K · filed 2021-03-01 | $14.98M 10-Q · filed 2020-08-07 | $22.10M derived: sum of 3 quarters · filed 2021-03-01 | $28.11M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $7.11M 10-K · filed 2021-03-01 | $14.23M derived: sum of 2 quarters · filed 2021-03-01 | $20.24M derived: sum of 3 quarters · filed 2021-03-01 | $26.40M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $7.12M 10-K · filed 2020-03-02 | $13.13M derived: sum of 2 quarters · filed 2020-03-02 | $19.29M derived: sum of 3 quarters · filed 2020-03-02 | $25.07M 10-K · filed 2021-03-01 |
| 2018-09-30 | $6.01M 10-K · filed 2020-03-02 | $12.17M derived: sum of 2 quarters · filed 2020-03-02 | $17.96M 10-Q · filed 2019-11-06 | $22.59M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $6.16M 10-K · filed 2020-03-02 | $11.95M 10-Q · filed 2019-08-08 | $16.58M derived: sum of 3 quarters · filed 2020-03-02 | $22.29M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $5.79M 10-K · filed 2020-03-02 | $10.42M derived: sum of 2 quarters · filed 2020-03-02 | $16.13M derived: sum of 3 quarters · filed 2020-03-02 | $21.66M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $4.63M 10-K · filed 2019-02-28 | $10.35M derived: sum of 2 quarters · filed 2019-02-28 | $15.87M derived: sum of 3 quarters · filed 2019-02-28 | $21.05M 10-K · filed 2020-03-02 |
| 2017-09-30 | $5.72M 10-K · filed 2019-02-28 | $11.24M derived: sum of 2 quarters · filed 2019-02-28 | $16.42M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $5.52M 10-K · filed 2019-02-28 | $10.70M 10-Q · filed 2018-08-06 | ||
| 2017-03-31 | $5.18M 10-K · filed 2019-02-28 | |||
| 2016-12-31 | $16.18M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |